Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine

被引：18
|
作者：
Obando, I. [1 ]
Arroyo, L. A. [1 ]
Sanchez-Tatay, D. [1 ]
Tarrago, D. [1 ]
Moreno, D. [1 ]
Hausdorff, W. P. [1 ]
Brueggemann, A. B. [1 ]
机构：
[1] Hosp Virgen Rocio, Pediat Infect Dis Unit, Seville, Spain
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2007年 / 13卷 / 03期
关键词：
D O I：
10.1111/j.1469-0691.2006.01646.x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
下载
收藏
页码：347 / 348
页数：3
相关论文
共 50 条
  • [21] Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente
    Black, S
    Shinefield, H
    Baxter, R
    Austrian, R
    Bracken, L
    Hansen, J
    Lewis, E
    Fireman, B
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (06) : 485 - 489
  • [22] Pneumococcal pneumonia in the era of heptavalent pneumococcal conjugate vaccine
    Payeras, Antoni
    Villoslada, Aroa
    Garau, Margarita
    Borras, Maria
    Pareja, Antonio
    Beingolea, David
    Garcia-Gasalla, Mercedes
    del Carmen Gallegos, M.
    Jose Alonso-Villaverde, Carlos
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2011, 29 (04): : 250 - 256
  • [23] Pneumococcal meningitis: impact of heptavalent pneumococcal conjugate vaccine
    Bingen, E.
    Levy, C.
    Varon, E.
    Lecuyer, A.
    Aujard, Y.
    Cohen, R.
    ARCHIVES DE PEDIATRIE, 2008, 15 (05): : 543 - 544
  • [24] Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults
    Black, S
    Shinefield, H
    Baxter, R
    Austrian, R
    Elvin, L
    Hansen, J
    Lewis, E
    Fireman, B
    VACCINE, 2006, 24 : S79 - S80
  • [25] Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme
    Harboe, Zitta B.
    Valentiner-Branth, Palle
    Benfield, Thomas L.
    Christensen, Jens Jorgen
    Andersen, Peter H.
    Howitz, Michael
    Krogfelt, Karen A.
    Lambertsen, Lotte
    Konradsen, Helle B.
    VACCINE, 2010, 28 (14) : 2642 - 2647
  • [26] Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine
    Perez-Trallero, E.
    Marimon, J. M.
    Ercibengoa, M.
    Vicente, D.
    Perez-Yarza, E. G.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2009, 28 (07) : 731 - 738
  • [27] Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine
    E. Pérez-Trallero
    J. M. Marimon
    M. Ercibengoa
    D. Vicente
    E. G. Pérez-Yarza
    European Journal of Clinical Microbiology & Infectious Diseases, 2009, 28 : 731 - 738
  • [28] Epidemiology of invasive pneumococcal disease in Southern California: Implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial
    Zangwill, KM
    Vadheim, CM
    Vannier, AM
    Hemenway, LS
    Greenberg, DP
    Ward, JI
    JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04): : 752 - 759
  • [29] Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine
    Elemraid, Mohamed A.
    Sails, Andrew D.
    Eltringham, Gary J. A.
    Perry, John D.
    Rushton, Stephen P.
    Spencer, David A.
    Thomas, Matthew F.
    Eastham, Katherine M.
    Hampton, Fiona
    Gennery, Andrew R.
    Clark, Julia E.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (06) : 1595 - 1603
  • [30] Epidemiology of invasive pneumococcal disease in BC during the introduction of conjugated pneumococcal vaccine
    Winters, Meghan
    Patrick, David M.
    Marra, Fawziah
    Buxton, Jane
    Chong, Mei
    Isaac-Renton, Judith L.
    Shaw, Carol
    Tyrrell, Gregory J.
    Lovgren, Marguerite
    Paulus, Stephane
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2008, 99 (01): : 57 - 61
12345